Correlation Between Reviva Pharmaceuticals and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Apellis Pharmaceuticals.
Diversification Opportunities for Reviva Pharmaceuticals and Apellis Pharmaceuticals
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Reviva and Apellis is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Reviva Pharmaceuticals and Apellis Pharmaceuticals
Given the investment horizon of 90 days Reviva Pharmaceuticals is expected to generate 1.32 times less return on investment than Apellis Pharmaceuticals. In addition to that, Reviva Pharmaceuticals is 2.15 times more volatile than Apellis Pharmaceuticals. It trades about 0.09 of its total potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.26 per unit of volatility. If you would invest 2,726 in Apellis Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 667.00 from holding Apellis Pharmaceuticals or generate 24.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Reviva Pharmaceuticals Holding vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Reviva Pharmaceuticals |
| Apellis Pharmaceuticals |
Reviva Pharmaceuticals and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reviva Pharmaceuticals and Apellis Pharmaceuticals
The main advantage of trading using opposite Reviva Pharmaceuticals and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Reviva Pharmaceuticals vs. Tff Pharmaceuticals | Reviva Pharmaceuticals vs. Eliem Therapeutics | Reviva Pharmaceuticals vs. Inhibrx | Reviva Pharmaceuticals vs. Enliven Therapeutics |
| Apellis Pharmaceuticals vs. Tff Pharmaceuticals | Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. Inhibrx | Apellis Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |